Opus Genetics’ BIRD-1 trial explores OPGx-BEST1 gene therapy for Best disease, focusing on safety, tolerability, and preliminary efficacy in retinal …
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.